Fortress Biotech, Inc. (FBIOP) Operating cash flow 2016–2025
Fortress Biotech, Inc. (FBIOP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$65.8MFY2025 · since FY2016: -$45.8M → -$65.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65.8M | +18.0% |
| FY2024 | -$80.2M | +37.5% |
| FY2023 | -$128.2M | +28.5% |
| FY2022 | -$179.4M | -53.9% |
| FY2021 | -$116.5M | -39.3% |
| FY2020 | -$83.7M | +11.9% |
| FY2019 | -$95.0M | +3.9% |
| FY2018 | -$98.8M | -21.6% |
| FY2017 | -$81.3M | -77.5% |
| FY2016 | -$45.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice